{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:25:47Z","timestamp":1790630747244,"version":"4.1.0"},"reference-count":60,"publisher":"The Endocrine Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,6,1]]},"abstract":"<jats:p>Insulin resistance plays a major role in the development and progression of cardiac hypertrophy and heart failure. Heart failure in turn promotes insulin resistance and increases the risk for diabetes. The vicious cycle determines significant mortality in patients with heart failure and diabetes. However, the underlying mechanisms for the vicious cycle are not fully elucidated. Here we show that circulating levels and adipose expression of retinol-binding protein 4 (RBP4), an adipokine that contributes to systemic insulin resistance, were elevated in cardiac hypertrophy induced by transverse aortic constriction and angiotensin-II (Ang-II) infusion. Ang-II increased RBP4 expression in adipocytes, which was abolished by losartan, an Ang-II receptor blocker. The elevated RBP4 in cardiac hypertrophy may have pathophysiological consequences because RBP4 increased cell size, enhanced protein synthesis, and elevated the expression of hypertrophic markers including Anp, Bnp, and Myh7 in primary cardiomyocytes. Mechanistically, RBP4 induced the expression and activity of toll-like receptor 4 (TLR4) and myeloid differentiation primary response gene 88 (MyD88) in cardiomyocytes, resulting in enhanced inflammation and reactive oxygen species production. Inhibition or knockdown of the TLR4\/MyD88 pathway attenuated inflammatory and hypertrophic responses to RBP4 stimulation. Importantly, RBP4 also reduced the expression of glucose transporter-4 and impaired insulin-stimulated glucose uptake in cardiomyocytes. This impairment was ameliorated in cardiomyocytes from TLR4 knockout mice. Therefore, RBP4 may be a critical modulator promoting the vicious cycle of insulin resistance and heart failure by activating TLR4\/MyD88-mediated inflammatory pathways. Potentially, lowering RBP4 might break the vicious cycle and improve both insulin resistance and cardiac hypertrophy.<\/jats:p>","DOI":"10.1210\/en.2015-2022","type":"journal-article","created":{"date-parts":[[2016,4,21]],"date-time":"2016-04-21T17:01:27Z","timestamp":1461258087000},"page":"2282-2293","source":"Crossref","is-referenced-by-count":60,"title":["Retinol-Binding Protein 4 Induces Cardiomyocyte Hypertrophy by Activating TLR4\/MyD88 Pathway"],"prefix":"10.1210","volume":"157","author":[{"given":"Wei","family":"Gao","sequence":"first","affiliation":[{"name":"Department of Geriatrics (W.G., Z.-X.L., X.L.), the Second Affiliated Hospital of Nanjing Medical University, Nanjing 210011, China;"},{"name":"Department of Medicine, Physiology, and Biophysics (W.G., L.Z., Y.C., J.-Z.B., Q.Y.), Center for Diabetes Research and Treatment, Center for Epigenetics and Metabolism, University of California, Irvine, Irvine, California 92697;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Cardiology (H.W., L.-S.W.), the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Medicine, Physiology, and Biophysics (W.G., L.Z., Y.C., J.-Z.B., Q.Y.), Center for Diabetes Research and Treatment, Center for Epigenetics and Metabolism, University of California, Irvine, Irvine, California 92697;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Cao","sequence":"first","affiliation":[{"name":"Department of Medicine, Physiology, and Biophysics (W.G., L.Z., Y.C., J.-Z.B., Q.Y.), Center for Diabetes Research and Treatment, Center for Epigenetics and Metabolism, University of California, Irvine, Irvine, California 92697;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Zhang","family":"Bao","sequence":"first","affiliation":[{"name":"Department of Cardiology (H.W., L.-S.W.), the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Xia","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Geriatrics (W.G., Z.-X.L., X.L.), the Second Affiliated Hospital of Nanjing Medical University, Nanjing 210011, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian-Sheng","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Cardiology (H.W., L.-S.W.), the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Medicine, Physiology, and Biophysics (W.G., L.Z., Y.C., J.-Z.B., Q.Y.), Center for Diabetes Research and Treatment, Center for Epigenetics and Metabolism, University of California, Irvine, Irvine, California 92697;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Lu","sequence":"first","affiliation":[{"name":"Department of Geriatrics (W.G., Z.-X.L., X.L.), the Second Affiliated Hospital of Nanjing Medical University, Nanjing 210011, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2016,4,21]]},"reference":[{"key":"2020071612005050600_B1","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.hfc.2012.06.005","article-title":"Insulin resistance and heart failure: molecular mechanisms","volume":"8","author":"Aroor","year":"2012","journal-title":"Heart Fail Clin"},{"key":"2020071612005050600_B2","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.hfc.2012.06.007","article-title":"Diabetic cardiomyopathy: bench to bedside","volume":"8","author":"Schilling","year":"2012","journal-title":"Heart Fail Clin"},{"key":"2020071612005050600_B3","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/S0002-9149(99)00097-1","article-title":"Prognostic importance of insulin-mediated glucose uptake in aged patients with congestive heart failure secondary to mitral and\/or aortic valve disease","volume":"83","author":"Paolisso","year":"1999","journal-title":"Am J Cardiol"},{"key":"2020071612005050600_B4","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/0026-0495(91)90075-8","article-title":"Insulin resistance and hyperinsulinemia in patients with chronic congestive heart failure","volume":"40","author":"Paolisso","year":"1991","journal-title":"Metabolism"},{"key":"2020071612005050600_B5","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jacc.2005.02.093","article-title":"Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure","volume":"46","author":"Doehner","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2020071612005050600_B6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/eurjhf\/hfq204","article-title":"Improved diabetic control in advanced heart failure patients treated with left ventricular assist devices","volume":"13","author":"Uriel","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"2020071612005050600_B7","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jchf.2013.04.009","article-title":"Adrenergic activation, fuel substrate availability, and insulin resistance in patients with congestive heart failure","volume":"1","author":"Uriel","year":"2013","journal-title":"JACC Heart Fail"},{"key":"2020071612005050600_B8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cmet.2011.12.006","article-title":"p53-induced adipose tissue inflammation is critically involved in the development of insulin resistance in heart failure","volume":"15","author":"Shimizu","year":"2012","journal-title":"Cell Metab"},{"key":"2020071612005050600_B9","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/BF02938356","article-title":"Role of inflammation in the progression of heart failure","volume":"9","author":"Yndestad","year":"2007","journal-title":"Curr Cardiol Rep"},{"key":"2020071612005050600_B10","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1126\/science.282.5396.2085","article-title":"Defective LPS signaling in C3H\/HeJ and C57BL\/10ScCr mice: mutations in Tlr4 gene","volume":"282","author":"Poltorak","year":"1998","journal-title":"Science"},{"key":"2020071612005050600_B11","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1161\/CIRCRESAHA.107.101104","article-title":"Innate immune pathway links obesity to insulin resistance","volume":"100","author":"Shah","year":"2007","journal-title":"Circ Res"},{"key":"2020071612005050600_B12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/CIRCRESAHA.107.158220","article-title":"Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction","volume":"102","author":"Timmers","year":"2008","journal-title":"Circ Res"},{"key":"2020071612005050600_B13","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1053-2498(03)00106-2","article-title":"Increased toll-like receptor 4 in the myocardium of patients requiring left ventricular assist devices","volume":"23","author":"Birks","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"2020071612005050600_B14","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.cardiores.2005.05.025","article-title":"Reduced cardiac hypertrophy in toll-like receptor 4-deficient mice following pressure overload","volume":"68","author":"Ha","year":"2005","journal-title":"Cardiovasc Res"},{"key":"2020071612005050600_B15","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1093\/eurjhf\/hfr035","article-title":"The toll-like receptor 4-antagonist eritoran reduces murine cardiac hypertrophy","volume":"13","author":"Ehrentraut","year":"2011","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"2020071612005050600_B16","doi-asserted-by":"crossref","first-page":"833","DOI":"10.5551\/jat.27292","article-title":"Angiotensin activates MCP-1 and induces cardiac hypertrophy and dysfunction via Toll-like receptor 4","volume":"22","author":"Matsuda","year":"2015","journal-title":"J Atheroscler Thromb"},{"key":"2020071612005050600_B17","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1210\/edrv-10-3-308","article-title":"Retinol-binding protein: the serum transport protein for vitamin A","volume":"10","author":"Blaner","year":"1989","journal-title":"Endocr Rev"},{"key":"2020071612005050600_B18","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature03711","article-title":"Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes","volume":"436","author":"Yang","year":"2005","journal-title":"Nature"},{"key":"2020071612005050600_B19","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1056\/NEJMoa054862","article-title":"Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects","volume":"354","author":"Graham","year":"2006","journal-title":"N Engl J Med"},{"key":"2020071612005050600_B20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cmet.2007.06.002","article-title":"Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass","volume":"6","author":"Kloting","year":"2007","journal-title":"Cell Metab"},{"key":"2020071612005050600_B21","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.2337\/db09-0216","article-title":"Adipose tissue exosome-like vesicles mediate activation of macrophage-induced insulin resistance","volume":"58","author":"Deng","year":"2009","journal-title":"Diabetes"},{"key":"2020071612005050600_B22","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1128\/MCB.06193-11","article-title":"Retinol-binding protein 4 inhibits insulin signaling in adipocytes by inducing proinflammatory cytokines in macrophages through a c-Jun N-terminal kinase- and toll-like receptor 4-dependent and retinol-independent mechanism","volume":"32","author":"Norseen","year":"2012","journal-title":"Mol Cell Biol"},{"key":"2020071612005050600_B23","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/ajh.2009.116","article-title":"Retinol-binding protein-4 in women with untreated essential hypertension","volume":"22","author":"Solini","year":"2009","journal-title":"Am J Hypertens"},{"key":"2020071612005050600_B24","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1507\/endocrj.K10E-054","article-title":"Associations of metabolic factors, especially serum retinol-binding protein 4 (RBP4), with blood pressure in Japanese\u2014the Tanno and Sobetsu study","volume":"57","author":"Chiba","year":"2010","journal-title":"Endocr J"},{"key":"2020071612005050600_B25","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1758-5996-6-72","article-title":"Serum retinol-binding protein 4 levels are elevated but do not contribute to insulin resistance in newly diagnosed Chinese hypertensive patients","volume":"6","author":"Deng","year":"2014","journal-title":"Diabetol Metab Syndr"},{"key":"2020071612005050600_B26","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.atherosclerosis.2010.07.063","article-title":"Relation between retinol, retinol-binding protein 4, transthyretin and carotid intima media thickness","volume":"213","author":"Bobbert","year":"2010","journal-title":"Atherosclerosis"},{"key":"2020071612005050600_B27","doi-asserted-by":"crossref","first-page":"e92739","DOI":"10.1371\/journal.pone.0092739","article-title":"Retinol binding protein 4 concentrations relate to enhanced atherosclerosis in obese patients with rheumatoid arthritis","volume":"9","author":"Dessein","year":"2014","journal-title":"PloS One"},{"key":"2020071612005050600_B28","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.atherosclerosis.2014.05.957","article-title":"The relationship of novel adipokines, RBP4 and omentin-1, with carotid atherosclerosis severity and vulnerability","volume":"235","author":"Kadoglou","year":"2014","journal-title":"Atherosclerosis"},{"key":"2020071612005050600_B29","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1161\/CIRCULATIONAHA.113.002073","article-title":"Plasma retinol-binding protein 4 (RBP4) levels and risk of coronary heart disease: a prospective analysis among women in the Nurses' Health Study","volume":"127","author":"Sun","year":"2013","journal-title":"Circulation"},{"key":"2020071612005050600_B30","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/eci.12229","article-title":"Retinol-binding protein 4 levels and susceptibility to ischaemic events in men","volume":"44","author":"Cubedo","year":"2014","journal-title":"Eur J Clin Invest"},{"key":"2020071612005050600_B31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12933-014-0121-z","article-title":"Serum levels of retinol-binding protein-4 are associated with the presence and severity of coronary artery disease","volume":"13","author":"Lambadiari","year":"2014","journal-title":"Cardiovasc Diabetol"},{"key":"2020071612005050600_B32","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.atherosclerosis.2014.11.016","article-title":"Circulating retinol binding protein 4 is associated with coronary lesion severity of patients with coronary artery disease","volume":"238","author":"Liu","year":"2015","journal-title":"Atherosclerosis"},{"key":"2020071612005050600_B33","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1253\/circj.CJ-12-0350","article-title":"Increased levels of retinol binding protein 4 in patients with advanced heart failure correct after hemodynamic improvement through ventricular assist device placement","volume":"76","author":"Chavarria","year":"2012","journal-title":"Circ J"},{"key":"2020071612005050600_B34","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.cmet.2014.01.018","article-title":"RBP4 activates antigen-presenting cells, leading to adipose tissue inflammation and systemic insulin resistance","volume":"19","author":"Moraes-Vieira","year":"2014","journal-title":"Cell Metab"},{"key":"2020071612005050600_B35","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.cmet.2015.09.002","article-title":"Activation of cardiac fibroblast growth factor receptor 4 causes left ventricular hypertrophy","volume":"22","author":"Grabner","year":"2015","journal-title":"Cell Metab"},{"key":"2020071612005050600_B36","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/nature14508","article-title":"HIF-driven SF3B1 induces KHK-C to enforce fructolysis and heart disease","volume":"522","author":"Mirtschink","year":"2015","journal-title":"Nature"},{"key":"2020071612005050600_B37","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1042\/CS20140460","article-title":"Hydrogen sulfide attenuates the development of diabetic cardiomyopathy","volume":"128","author":"Zhou","year":"2015","journal-title":"Clin Sci (Lond)"},{"key":"2020071612005050600_B38","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1210\/en.2013-1817","article-title":"Protein kinase B (PKB\/AKT1) formed signaling complexes with mitochondrial proteins and prevented glycolytic energy dysfunction in cultured cardiomyocytes during ischemia-reperfusion injury","volume":"155","author":"Deng","year":"2014","journal-title":"Endocrinology"},{"key":"2020071612005050600_B39","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1161\/CIRCRESAHA.114.302476","article-title":"The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489","volume":"114","author":"Wang","year":"2014","journal-title":"Circ Res"},{"key":"2020071612005050600_B40","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.bbadis.2014.04.027","article-title":"SIRT2 negatively regulates insulin resistance in C2C12 skeletal muscle cells","volume":"1842","author":"Arora","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"2020071612005050600_B41","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1096\/fj.14-266064","article-title":"Novel role for retinol-binding protein 4 in the regulation of blood pressure","volume":"29","author":"Kraus","year":"2015","journal-title":"FASEB J"},{"key":"2020071612005050600_B42","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1093\/emboj\/18.17.4633","article-title":"Impaired retinal function and vitamin A availability in mice lacking retinol-binding protein","volume":"18","author":"Quadro","year":"1999","journal-title":"EMBO J"},{"key":"2020071612005050600_B43","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1074-7613(04)00046-9","article-title":"NALP3 forms an IL-1\u03b2-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder","volume":"20","author":"Agostini","year":"2004","journal-title":"Immunity"},{"key":"2020071612005050600_B44","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1136\/hrt.2005.068270","article-title":"Oxidative stress and redox signalling in cardiac hypertrophy and heart failure","volume":"93","author":"Seddon","year":"2007","journal-title":"Heart"},{"key":"2020071612005050600_B45","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.cmet.2007.02.006","article-title":"STRA6, a cell-surface receptor for retinol-binding protein: the plot thickens","volume":"5","author":"Blaner","year":"2007","journal-title":"Cell Metab"},{"key":"2020071612005050600_B46","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.yjmcc.2012.01.021","article-title":"MyD88 mediated inflammatory signaling leads to CaMKII oxidation, cardiac hypertrophy and death after myocardial infarction","volume":"52","author":"Singh","year":"2012","journal-title":"J Mol Cell Cardiol"},{"key":"2020071612005050600_B47","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11897-009-0014-8","article-title":"Insulin resistance and heart failure","volume":"6","author":"Heck","year":"2009","journal-title":"Curr Heart Fail Rep"},{"key":"2020071612005050600_B48","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1007\/s00018-011-0690-x","article-title":"Subcellular trafficking of the substrate transporters GLUT4 and CD36 in cardiomyocytes","volume":"68","author":"Steinbusch","year":"2011","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"2020071612005050600_B49","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.trsl.2015.08.011","article-title":"Molecular and cellular mechanisms linking inflammation to insulin resistance and beta-cell dysfunction","volume":"167","author":"Khodabandehloo","year":"2016","journal-title":"Transl Res"},{"key":"2020071612005050600_B50","doi-asserted-by":"crossref","first-page":"14488","DOI":"10.1038\/srep14488","article-title":"Chronic TLR stimulation controls NLRP3 inflammasome activation through il-10 mediated regulation of NLRP3 expression and caspase-8 activation","volume":"5","author":"Gurung","year":"2015","journal-title":"Sci Rep"},{"key":"2020071612005050600_B51","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.cardfail.2015.04.014","article-title":"The importance of NLRP3 inflammasome in heart failure","volume":"21","author":"Butts","year":"2015","journal-title":"J Card Fail"},{"key":"2020071612005050600_B52","doi-asserted-by":"crossref","first-page":"30269","DOI":"10.3390\/ijms161226225","article-title":"Oxidative stress and inflammation in hepatic diseases: therapeutic possibilities of N-acetylcysteine","volume":"16","author":"de Andrade","year":"2015","journal-title":"Int J Mol Sci"},{"key":"2020071612005050600_B53","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1550-2783-2-2-38","article-title":"The antioxidant role of glutathione and N-acetyl-cysteine supplements and exercise-induced oxidative stress","volume":"2","author":"Kerksick","year":"2005","journal-title":"J Int Soc Sports Nutr"},{"key":"2020071612005050600_B54","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/CIRCRESAHA.116.303697","article-title":"Inflammation, immunity, and hypertensive end-organ damage","volume":"116","author":"McMaster","year":"2015","journal-title":"Circ Res"},{"key":"2020071612005050600_B55","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1038\/emm.2013.97","article-title":"Recognition of lipopolysaccharide pattern by TLR4 complexes","volume":"45","author":"Park","year":"2013","journal-title":"Exp Mol Med"},{"key":"2020071612005050600_B56","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1159\/000149815","article-title":"All-trans retinoic acid decreases murine adipose retinol binding protein 4 production","volume":"22","author":"Mercader","year":"2008","journal-title":"Cell Physiol Biochem"},{"key":"2020071612005050600_B57","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1467-789X.2011.00942.x","article-title":"The renin-angiotensin system: a link between obesity, inflammation and insulin resistance","volume":"13","author":"Kalupahana","year":"2012","journal-title":"Obes Rev"},{"key":"2020071612005050600_B58","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(07)60242-6","article-title":"Renin-angiotensin system and cardiovascular risk","volume":"369","author":"Schmieder","year":"2007","journal-title":"Lancet"},{"key":"2020071612005050600_B59","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11906-012-0323-2","article-title":"The renin angiotensin aldosterone system and insulin resistance in humans","volume":"15","author":"Underwood","year":"2013","journal-title":"Curr Hypertens Rep"},{"key":"2020071612005050600_B60","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/hr.2010.205","article-title":"Different actions of losartan and ramipril on adipose tissue activity and vascular remodeling biomarkers in hypertensive patients","volume":"34","author":"Derosa","year":"2011","journal-title":"Hypertens Res"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/157\/6\/2282\/8994023\/endo2282.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/157\/6\/2282\/8994023\/endo2282.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T18:34:14Z","timestamp":1594924454000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/157\/6\/2282\/2422475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,21]]},"references-count":60,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2015-2022","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,21]]}}}